Literature DB >> 18516758

MicroRNAs and cancer epigenetics.

Muller Fabbri1.   

Abstract

The term epigenetics refers to all heritable changes in gene expression that are not associated with concomitant alterations in the DNA sequence. Reversible DNA methylation and histone modifications are the hallmarks of epigenetic gene regulation. MicroRNAs (miRNAs) are a recently discovered category of noncoding RNAs with important regulatory functions. Aberrancies in both the epigenetic and in the miRNA regulation of genes have been documented in cancer. An increasing number of studies are showing that the abnormalities of the epigenome and of the miRNome are not independent and could be explained both by an epigenetic regulation of miRNA expression and by miRNA control on components of the epigenetic machinery. A deeper understanding of this correlation could lead to new therapeutic avenues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516758

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  16 in total

1.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

Review 2.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development.

Authors:  Hui Ling; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

3.  microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis.

Authors:  Larissa A Gregory; Rachel A Ricart; Shyam A Patel; Philip K Lim; Pranela Rameshwar
Journal:  Curr Cancer Ther Rev       Date:  2011-08

Review 4.  The realm of microRNAs in cancers.

Authors:  Nuray Varol; Ece Konac; O Serhat Gurocak; Sinan Sozen
Journal:  Mol Biol Rep       Date:  2010-06-20       Impact factor: 2.316

Review 5.  Role of epigenetic therapy in myelodysplastic syndrome.

Authors:  Tapan M Kadia; Guillermo Garcia-Manero
Journal:  Expert Rev Hematol       Date:  2008-12       Impact factor: 2.929

Review 6.  [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].

Authors:  A Schaefer; M Jung; G Kristiansen; M Lein; M Schrader; K Miller; A Erbersdobler; C Stephan; K Jung
Journal:  Urologe A       Date:  2009-08       Impact factor: 0.639

7.  Perspectives in cell cycle regulation: lessons from an anoxic vertebrate.

Authors:  Kyle K Biggar; Kenneth B Storey
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

8.  Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.

Authors:  Kwang-Hyuck Lee; Craig Lotterman; Collins Karikari; Noriyuki Omura; Georg Feldmann; Nils Habbe; Michael G Goggins; Joshua T Mendell; Anirban Maitra
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996

Review 9.  miRNA regulation of cytokine genes.

Authors:  Ananthi J Asirvatham; William J Magner; Thomas B Tomasi
Journal:  Cytokine       Date:  2009-01-01       Impact factor: 3.861

Review 10.  MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia.

Authors:  Justin L Mott
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.